Cargando…

Correction to: Diabetes, cardiovascular disease and the microcirculation

Detalles Bibliográficos
Autores principales:	Strain, W. David, Paldánius, P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196432/ https://www.ncbi.nlm.nih.gov/pubmed/34116669 http://dx.doi.org/10.1186/s12933-021-01307-5

Ejemplares similares

Diabetes, cardiovascular disease and the microcirculation
por: Strain, W. David, et al.
Publicado: (2018)

Correction to: Recruiting the microcirculation in septic shock
por: Legrand, Matthieu, et al.
Publicado: (2019)

Microcirculation and Cardiovascular Diseases
por: Tibiriçá, Eduardo, et al.
Publicado: (2018)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Correction: Direct assessment of microcirculation in shock: a randomized-controlled multicenter study
por: Bruno, Raphael Romano, et al.
Publicado: (2023)

Clinical Inertia in Individualising Care for Diabetes: Is There Time to do More in Type 2 Diabetes?
por: Strain, William David, et al.
Publicado: (2014)

Correction: Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction
por: Hollander, Maurits R., et al.
Publicado: (2016)

Correction: Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA)
por: Verma, Rajeev Kumar, et al.
Publicado: (2013)

Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL study
por: Strain, W. David, et al.
Publicado: (2017)

Perivascular Fat and the Microcirculation: Relevance to Insulin Resistance, Diabetes, and Cardiovascular Disease
por: Houben, A. J., et al.
Publicado: (2011)

Correction: Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI
por: Ma, Yuliang, et al.
Publicado: (2022)

Correction: Raposo et al. The Role of Food Supplementation in Microcirculation—A Comprehensive Review. Biology 2021, 10, 616
por: Raposo, António, et al.
Publicado: (2023)

Correction to: Updates on cardiovascular outcome trials in diabetes
por: Schnell, Oliver, et al.
Publicado: (2017)

Correction: Four Novel Loci (19q13, 6q24, 12q24, and 5q14) Influence the Microcirculation In Vivo
por: Ikram, M. Kamran, et al.
Publicado: (2010)

Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in time to do more in diabetes
por: Vencio, Sérgio, et al.
Publicado: (2017)

Microcirculation in Hypertension: A Therapeutic Target to Prevent Cardiovascular Disease?
por: Rizzoni, Damiano, et al.
Publicado: (2023)

Correction to: Triglycerides–glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease
Publicado: (2023)

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D&CVD) EASD Study Group
por: Schnell, Oliver, et al.
Publicado: (2017)

Correction: Evaluation of the Microcirculation in Chronic Thromboembolic Pulmonary Hypertension Patients: The Impact of Pulmonary Arterial Remodeling on Postoperative and Follow-Up Pulmonary Arterial Pressure and Vascular Resistance
por: Jujo, Takayuki, et al.
Publicado: (2015)

Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes
por: Athinarayanan, Shaminie J., et al.
Publicado: (2021)

Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals
por: Zhang, Ruiqi, et al.
Publicado: (2022)

Correction to: Different impacts of metabolic profiles on future risk of cardiovascular disease between diabetes with and without established cardiovascular disease: the Japan diabetes complication and its prevention prospective study 7 (JDCP study 7)
por: Takahara, Mitsuyoshi, et al.
Publicado: (2021)

Correction to: Exosomes in Cardiovascular Medicine
por: Dykes, Iain M.
Publicado: (2018)

Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
por: Sposito, Andrei C., et al.
Publicado: (2019)

Correction: Markers of Tissue-Specific Insulin Resistance Predict the Worsening of Hyperglycemia, Incident Type 2 Diabetes and Cardiovascular Disease
Publicado: (2014)

Correction: Relationship of Dickkopf1 (DKK1) with Cardiovascular Disease and Bone Metabolism in Caucasian Type 2 Diabetes Mellitus
Publicado: (2015)

Correction to: Cardiovascular disease (CVD): assessment, prediction and policy implications
por: Rehman, Shazia, et al.
Publicado: (2021)

Correction to: Locking the Revolving Door: Racial Disparities in Cardiovascular Disease
Publicado: (2023)

Correction to: Radiation‐Induced Cardiovascular Disease: Review of an Underrecognized Pathology
Publicado: (2023)

Correction: Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Publicado: (2021)

Author Correction: Optical coherence tomography angiography as a novel approach to contactless evaluation of sublingual microcirculation: A proof of principle study
por: Hessler, Michael, et al.
Publicado: (2020)

Correction to: Relationship between Azithromycin and Cardiovascular Outcomes in Unvaccinated Patients With COVID‐19 and Preexisting Cardiovascular Disease
Publicado: (2023)

Correction to: Sex differences in 10-year ischemic cardiovascular disease risk prediction in Chinese patients with prediabetes and type 2 diabetes
por: Yang, Lihong, et al.
Publicado: (2020)

Correction to: Development of models to predict 10-30-year cardiovascular disease risk using the Da Qing IGT and diabetes study
por: Chen, Fei, et al.
Publicado: (2023)

Correction: The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease
por: Borràs Sans, Mercè, et al.
Publicado: (2018)

Correction to: Mitochondrial DNA Content Is Linked to Cardiovascular Disease Patient Phenotypes
Publicado: (2021)

Correction: Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study
por: Raum, Philipp, et al.
Publicado: (2015)

Correction to: “Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes”
Publicado: (2022)

Correction: Soy and fish as features of the Japanese diet and cardiovascular disease risks
por: Yamori, Yukio, et al.
Publicado: (2017)

Regulation of Muscle Microcirculation in Health and Diabetes
por: Liu, Zhenqi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_k955q3sfh41fghrk585scv53im